WARM Act of 2023

Issues related to Pharmacy Benefit Manager reform (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act; H.R. 8223/S. 4246 Advancing Menopause and Mid-Life Womens Health Act; Issues related to Eye Screening and Access (no specific bills).

Client expense: $670,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act; H.R. 8223/S. 4246 Advancing Menopause and Mid-Life Womens Health Act; Issues related to Eye Screening and Access (no specific bills); Issues related to menopause; issues related to implementation of the Inflation Reduction Act.

Client expense: $670,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1826, Prostate-Specific Antigen Screening for High-risk Insured Men Act H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 Issues related to the treatment of menopause and women's health at mid-life Issues related to prostate cancer Issues related to vision health and awareness

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES

H.R. 1826, Prostate-Specific Antigen Screening for High-risk Insured Men Act H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 Issues related to the treatment of menopause and women's health at mid-life Issues related to prostate cancer Issues related to vision health and awareness

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES

Issues related to Pharmacy Benefit Manager reform (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act; H.R. 8223/S. 4246 Advancing Menopause and Mid-Life Womens Health Act; Issues related to Eye Screening and Access (no specific bills).

Client expense: $770,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act; H.R. 8223/S. 4246 Advancing Menopause and Mid-Life Womens Health Act; Issues related to Eye Screening and Access (no specific bills).

Client expense: $770,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 Issues related to the treatment of menopause and women's health at mid-life Issues related to prostate cancer Issues related to health equity

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 Issues related to the treatment of menopause and women's health at mid-life Issues related to prostate cancer Issues related to health equity

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Issues related to Pharmacy Benefit Manager reform (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act.

Client expense: $960,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills); Issues related to Patient Drug User Fee Reauthorization (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act.

Client expense: $960,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Women's health issues; WARM Act (H.R. 6743)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6743, the Were Addressing the Realities of Menopause Act. S. 3621/H.R. 1328, the Medical Device Nonvisual Accessibility Act. No bill number. Discussed Affordable Care Act enhanced subsidy expiration. No bill number. Discussed respiratory virus prevention. No bill number. Discussed artificial intelligence in health care. No bill number. Discussed Compassionate Care Act. S. 3254/H.R 7222, the Lowering Costs for Caregivers Act.

Client expense: $4,370,000 · Firm income: Not reported

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Inclusion of pregnant and lactating individuals in research (general); Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; H.R. 7056/S. 3612, Access to Family Building Act; H.R. 6918/S. 3741, Supporting Pregnant and Parenting Women and Families Act; H.R. 6914/S. 2974, Pregnant Students Rights Act; H.R. 7153/S. 3679, Dr. Lorna Breen Health Care Provider Protection Act; Family Health Affordability Act; S. 712, Connected MOM Act; H.R. 7050, Substance Use Disorder Workforce Act; H.R. 7059/S. 3983, ACCESS Act; Health Insurance Portability and Accountability Act (general); Patient-physician relationship (general); Menopause research, training, and education (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); H.R. 5568/S. 2846, CARE for Moms Act; H.R. 6743, WARM Act; Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Physician burnout (general); Maternal mental health (general); Artificial intelligence in health care (general); Coverage for infertility (general); Protections for in vitro fertilization (general); Restrictions on menthol cigarettes and flavored cigars (general); Obstetric unit closures (general); White House Initiative on Womens Health Research (general); COVID-19 vaccine (general); Vaccine safety systems (general); Pediatric Subspecialty Loan Repayment Program; Over-the-counter contraception (general)

H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 H.Res. 806, Expressing support for the recognition of October 2023, as "World Menopause Awareness Month" and expressing the sense of the House of Representatives regarding global awareness and access to care during the menopausal transition and post-menopause Issues related to the treatment of menopause Issues related to prostate cancer Issues related to health equity

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES

H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 H.Res. 806, Expressing support for the recognition of October 2023, as "World Menopause Awareness Month" and expressing the sense of the House of Representatives regarding global awareness and access to care during the menopausal transition and post-menopause Issues related to the treatment of menopause Issues related to prostate cancer Issues related to health equity

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES

Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Women's health issues; WARM Act (H.R. 6743)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural and underserved areas (general); H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); Cost-sharing for maternity care (general); menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); H.R. 5568/S. 2846, CARE for Moms Act; H.R. 5909, Caring for Grieving Families Act of 2023; S. 3509, Healthy MOM Act; H.R. 6746, Iron Deficiency Education and Awareness Act; H.R. 6743, WARM Act; H.R. 6103/S. 3137, Support Through Loss Act; S. 3070, Youth Prevention and Recovery Authorization Act of 2023; reproductive health data privacy (general); Treatment of reproductive health information under the Stored Communications Act (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); Physician burnout (general); Maternal mental health (general); Artificial intelligence in health care (general); Coverage for infertility (general); Restrictions on menthol cigarettes and flavored cigars (general); Obstetric unit closures (general); Doxycycline Post-Exposure Prophylaxis (general); White House Initiative on Womens Health Research (general); Plans of Safe Care (general); Section 504 nondiscrimination on the basis of disability (general)